Literature DB >> 17578380

The leptin melanocortin pathway and the control of body weight: lessons from human and murine genetics.

A Oswal1, G S H Yeo.   

Abstract

The recent rapid increase in the prevalence of obesity across the world is undoubtedly due to changes in diet and lifestyle. However, it is also indisputable that different people react differently to this change in environment and this variation in response is likely to be genetically determined. While for the majority of people this effect is presumed to be polygenic in origin, there is now strong evidence for a small number of genes having a large effect in some families with severe obesity. Studies of these families, coupled with parallel studies in murine models, have provided novel insights into the molecules involved in the regulation of appetite, energy expenditure and nutrient partitioning. We review here the lessons we have learnt from mouse models of obesity, both naturally occurring and artificially generated through targeted gene deletions, and more importantly from human monogenic syndromes of obesity. These have illuminated the critical role in which the central leptin melanocortin pathway plays in the control of mammalian food intake and body weight.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17578380     DOI: 10.1111/j.1467-789X.2007.00378.x

Source DB:  PubMed          Journal:  Obes Rev        ISSN: 1467-7881            Impact factor:   9.213


  24 in total

1.  Central melanocortin signaling regulates cholesterol.

Authors:  Yi-Chun Loraine Tung; Giles S H Yeo
Journal:  Nat Neurosci       Date:  2010-07       Impact factor: 24.884

2.  The gliotransmitter ACBP controls feeding and energy homeostasis via the melanocortin system.

Authors:  Khalil Bouyakdan; Hugo Martin; Fabienne Liénard; Lionel Budry; Bouchra Taib; Demetra Rodaros; Chloé Chrétien; Éric Biron; Zoé Husson; Daniela Cota; Luc Pénicaud; Stephanie Fulton; Xavier Fioramonti; Thierry Alquier
Journal:  J Clin Invest       Date:  2019-04-02       Impact factor: 14.808

3.  Uncovering the biology of FTO.

Authors:  Giles S H Yeo; Stephen O'Rahilly
Journal:  Mol Metab       Date:  2012-08-03       Impact factor: 7.422

Review 4.  Central leptin and ghrelin signalling: comparing and contrasting their mechanisms of action in the brain.

Authors:  Xiaoye Shan; Giles S H Yeo
Journal:  Rev Endocr Metab Disord       Date:  2011-09       Impact factor: 6.514

Review 5.  Cognitive and autonomic determinants of energy homeostasis in obesity.

Authors:  Denis Richard
Journal:  Nat Rev Endocrinol       Date:  2015-06-30       Impact factor: 43.330

6.  Four out of eight genes in a mouse chromosome 7 congenic donor region are candidate obesity genes.

Authors:  Kari A Sarahan; Janis S Fisler; Craig H Warden
Journal:  Physiol Genomics       Date:  2011-07-05       Impact factor: 3.107

7.  Effect of the melanocortin-3 receptor Thr6Lys and Val81Ile genetic variants on body composition and substrate oxidation in Chilean obese children.

Authors:  Ana M Obregón; Erik Diaz; Jose L Santos
Journal:  J Physiol Biochem       Date:  2011-10-08       Impact factor: 4.158

8.  A novel MC4R mutation associated with childhood-onset obesity: A case report.

Authors:  Manpreet Doulla; Adam D McIntyre; Robert A Hegele; Patricia H Gallego
Journal:  Paediatr Child Health       Date:  2014-12       Impact factor: 2.253

9.  New mutations at the imprinted Gnas cluster show gene dosage effects of Gsα in postnatal growth and implicate XLαs in bone and fat metabolism but not in suckling.

Authors:  Sally A Eaton; Christine M Williamson; Simon T Ball; Colin V Beechey; Lee Moir; Jessica Edwards; Lydia Teboul; Mark Maconochie; Jo Peters
Journal:  Mol Cell Biol       Date:  2012-01-03       Impact factor: 4.272

10.  Targeted deletion of one or two copies of the G protein β subunit Gβ5 gene has distinct effects on body weight and behavior in mice.

Authors:  Qiang Wang; Konstantin Levay; Tatyana Chanturiya; Galina Dvoriantchikova; Karen L Anderson; Suzy D C Bianco; Cintia B Ueta; R Damaris Molano; Antonello Pileggi; Eugenia V Gurevich; Oksana Gavrilova; Vladlen Z Slepak
Journal:  FASEB J       Date:  2011-07-30       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.